The bacteria behind the sexually transmitted disease gonorrhea is known for developing antibiotic resistance. Now there are two new treatment options.

On Friday, the F.D.A. approved a new antibiotic, zoliflodacin, a day after an article published in The Lancet reported that a ...

Turning the tide on antibiotic resistance will require new ways of working, writes executive director of the Global ...

For the first time in decades, the US Food and Drug Administration has signed off on new antibiotics to fight gonorrhea. The approvals come at a critical moment: The sexually transmitted infection is ...

Zoliflodacin is the first of a new class of antibiotics, called spiropyrimidinetriones, that have activity against Neisseria ...

Gonorrhea is a common sexually transmitted infection caused by the bacterium Neisseria gonorrhoeae. It primarily infects the ...

Zoliflodacin, which will be marketed under the name Nuzolvence, is the first new drug to uniquely target gonorrhea infections ...

After a three-decade drought of new antibiotics to treat gonorrhea, the FDA has signed off on two first-in-class oral ...

The U.S. Food and Drug Administration said on Thursday it has expanded the use of GSK's Blujepa as an oral treatment for ...

For the first time in nearly 40 years, the FDA approved a new antibiotic to treat gonorrhea, an STI that has grown ...

Merck & Co. is turning down its option to license Evaxion’s gonorrhea vaccine candidate, closing the door on the Danish ...

The FDA approved gepotidacin (Blujepa), an oral option for the treatment of uncomplicated urogenital gonorrhea among patients ...